Continuing Education  » Oncology  » Pet Cancer Summit - Session 2: Cancer and Diagnostics - What is helpful? What is hype o...

Pet Cancer Summit - Session 2: Cancer and Diagnostics - What is helpful? What is hype or truly offers hope?

CE Event Information

  • Description:
    The mention of 'cancer' can evoke a wide range of emotions ranging from fear to concern to confusion. Understanding the diagnostic process and the spectrum of care available is essential to determining the best path forward for an individual family and their pet.

    A wide array of diagnostic tests have emerged in the marketplace in recent years - all in an effort to support our ability to diagnose various cancer types in companion animals. Some have even come to market with little scientific rigor to support their utility. So, how are primary care veterinarians and pet owners to discern the best path forward? What is hype, what is helpful, and what truly offers hope?

    Dr. Thamm will kick off this session discussing several new cancer diagnostic tools that caretakers should know about including: custom tumor-specific prognostic panels, blood-based screening tests, chemotherapy sensitivity tests, and DNA mutation-based testing. He will explain how and when to use these tests, and will highlight which are useful and the types of cases that might benefit from their use.

    We will then turn our focus to the diagnostic approaches for lymphoma patients. Dr. Tripp will detail the tests that are available (flow cytometry, PARR, IHC, and ICC stains) and explain how primay care veterinarians can set patients up for success prior to referral to a veterinary oncologist.

    Running time: 1 hr 20 mins (including 18 mins of question and answer)

    Registration is FREE for VetVine Premium Membership subscribers.
  • Sponsor: VetVine, PetCure Oncology; Virginia Tech Animal Cancer Care and Research Center; University of Missouri Veterinary Health Center Oncology Service;, Companion Animal Euthanasia Training Academy; Lap of Love
  • Presenter(s): Douglas Thamm, VMD, DACVIM (Oncology);, Chelsea Tripp, DVM, MS, DACVIM (Oncology)
  • Fee (Basic Membership): $36